News Medical on MSN1d
A molecule is shown to produce cognitive improvement in rodents with early Alzheimer's diseaseThe UPV/EHU's Neurochemistry and Neurodegeneration group has come up with a drug that is a potential candidate for tackling ...
Research highlights the therapeutic potential of targeting cannabinoid receptors to counter memory impairment in early ...
M1 receptors, present on the cholinergic ganglia, with the role of facilitating neural transmission; M2 receptors, located on the postganglion endings of the cholinergic fibers, with the role of ...
News Medical on MSN2d
Study uncovers mechanism for cognitive improvement in dementiaA University of the Basque Country (UPV/EHU) study proves that the WIN55.212-2 drug protects the brain and reverses the initial cognitive damage caused by dementia, and explains how it works ...
Scripps News on MSN3mon
FDA approves first new medication to treat schizophrenia in more than 30 yearsThe U.S. Food and Drug Administration approved a new schizophrenia treatment on Thursday for the first time in decades, ...
Our recent work (McQuail & Burk, 2006) suggests that cholinergic muscarinic receptors, particularly the muscarinic M1 receptor, are important for mediating the effects of the cortical acetylcholine on ...
A University of the Basque Country (UPV/EHU) study proves that the WIN55.212-2 drug protects the brain and reverses the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback